Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) [Phase 3]
A Phase 3 trial of the renin inhibitor aliskiren in Type 2 Diabetes mellitus evaluating cardiovascular and renal outcomes (Core and Extensio…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Walnuts and Glucose Variability [NA]
A clinical trial examining whether walnuts influence glucose variability in people with Type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Macronutrients and Gut Hormone Secretion [NA]
This ClinicalTrials.gov entry reports a completed Lund University study on how macronutrients influence gut hormone secretion in individuals…
-
CLINICAL_TRIALS research · 2014-03-17Clinical Trial Update: Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 study is evaluating the efficacy and safety of adding gemigliptin 50 mg once daily to ongoing glimepiride as a fixed-dose combinat…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEAD
An ancillary study within LOOK AHEAD, evaluating biomarkers of oxidative stress, has completed, providing biomarker data from participants w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Janssen - Glucose Regulation/Risp/Olanz [NA]
A Janssen-sponsored study evaluating glucose regulation in schizophrenia patients treated with risperidone or olanzapine has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Pfizer/IVGTT/Ziprasidone/Olanzapine [NA]
This clinical trial update reports completion of a study involving ziprasidone and olanzapine in schizophrenia and type 2 diabetes mellitus.…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy
This clinical trial update reports an MRI-based study of liver steatosis in patients with metabolic steatopathy. The cohort includes individ…
-
CLINICAL_TRIALS research · 2014-03-12Clinical Trial Update: Mechanisms Behind Antidiabetic Effects by Gastric By-pass [NA]
A completed clinical trial from Karolinska Institutet investigates the mechanisms behind the antidiabetic effects of gastric bypass surgery …
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery [Phase 4]
A Phase 4 trial comparing basal-bolus insulin versus an SSRI in patients with Type 2 diabetes undergoing general surgery completed, with res…
-
FDA approval · 2014-03-11FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. The approval …
-
CLINICAL_TRIALS research · 2014-03-07Clinical Trial Update: Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
An update on the Look AHEAD study examining sleep apnea in people with Type 2 Diabetes; the current trial status is unknown.
-
FDA approval · 2014-03-04FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk.
-
FDA approval · 2014-03-04FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) by Eli Lilly and Company.
-
FDA approval · 2014-03-04FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The approval covers changes to the product's lab…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients [Phase 4]
A Phase 4 clinical trial evaluating liraglutide's impact on kidney function in adults with type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS research · 2014-02-28Clinical Trial Update: The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance
This clinical trial study examines how health beliefs and uncertainty influence treatment adherence in Type 2 diabetes mellitus.
-
FDA approval · 2014-02-27FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Bromocriptine Mesylate from ANI Pharmaceuticals, Inc., resulting in an updated approval for …
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial update on insulin lispro in participants with inadequately controlled Type 2 diabetes, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects [Phase 4]
Phase 4 trial evaluating the efficacy of pioglitazone plus metformin in Bangladeshi adults with Type 2 Diabetes Mellitus, and exploring whet…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: The Acute Effect of Interval-walking [NA]
This clinical trial update reports on the acute effects of interval-walking in individuals with Type 2 Diabetes Mellitus and notes that the …
-
FDA approval · 2014-02-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk, representing an approved change to the existing BLA.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Acute Effect of Intensive Insulin Infusion on Intestinal Triglyceride-rich-lipoprotein-apoB48 Metabolism in Type 2 Diabetic Patients [NA]
The clinical trial update reports on the acute effects of intensive insulin infusion on intestinal triglyceride-rich lipoprotein apoB48 meta…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: The CRONOS-ADM Registry
A registry trial led by Seoul St. Mary's Hospital examining asymptomatic patients with type 2 diabetes mellitus and atherosclerosis, includi…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253) [Phase 1]
Phase 1 trial evaluating the effects of glimepiride on recovery from hypoglycemia in adults with type 2 diabetes mellitus; study completed w…